Related Experiment Video

Updated: Jul 28, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Development of dendritic-cell based prostate cancer vaccine

B A Tjoa1, G P Murphy

  • 1Pacific Northwest Cancer Foundation, 13758 Lake City Way NE, Suite 200, Seattle, WA 98125, USA. benhenry@uswest.net

Immunology Letters
|September 21, 2000
PubMed

Insights

Novel dendritic cell vaccines offer a promising new avenue for treating metastatic prostate cancer by activating the patient's immune system. These advanced immunotherapies aim to overcome limitations of current treatments.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Metastatic prostate cancer lacks curative treatments.
  • Existing therapies show limited efficacy.
  • Novel treatment strategies are urgently needed.

Purpose of the Study:

  • To review advancements in active specific immunotherapy for metastatic prostate cancer.
  • To discuss dendritic cell-based vaccines as a novel treatment approach.
  • To summarize clinical trial outcomes of dendritic cell vaccines in prostate cancer.

Main Methods:

  • Review of current literature on cancer immunotherapy.
  • Focus on dendritic cell-based vaccine development.
  • Analysis of clinical trial data for peptide-pulsed autologous dendritic cell vaccines.

Main Results:

  • Dendritic cells are effective in delivering cancer antigens for T cell activation.
  • Dendritic cell-based prostate cancer vaccines show potential.
  • Clinical trials are evaluating the efficacy of these vaccines.

Conclusions:

  • Dendritic cell vaccines represent a promising immunotherapy for metastatic prostate cancer.
  • Further research and clinical trials are warranted.
  • This approach could offer an alternative to current treatment modalities.

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...